Drug Approval | March 22, 2022
Merck’s Keytruda approved for fourth gynecologic cancer indication
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
The drug is indicated for use in combination with other drugs
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The company plans to launch the product immediately
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Sputnik Light is the first component of Sputnik V
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
Subscribe To Our Newsletter & Stay Updated
